Delivery Order N0018924DZ018-W81K0026FA125
Award Date 5/26/26
Potential Completion Date 8/25/26
Potential Value $38K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army issued a delivery order to Microgenics Corporation on December 10, 2025, for MDMA/MDA reagent kits with a ceiling value of $12,518.40. The order is firm fixed price and matures January 1, 2026. Place of performance is Fort Meade, MD. This delivery order is issued under a parent IDV for MDMA/MDA reagent kits valued at $1,154,822.40. Microgenics Corporation, through its Clinical Diagnostics Division, manufactures immunoassay reagent test kits for clinical toxicology...
- The Bureau of Medicine and Surgery issued a $15,022.08 delivery order to Microgenics Corporation on May 4, 2026, for MDMA/MDA reagent kits, with an ultimate completion date of May 12, 2026. The order is firm fixed price with no set-aside. Place of performance is Fremont, CA. Microgenics manufactures immunoassay reagent test kits for clinical toxicology screening and substance detection to military and VA medical facilities. The company operates as a prime contractor with no subcontractors on...
- The Department of the Army Medical Command awarded a $34,913.10 firm fixed price delivery order to Microgenics Corporation, a Clinical Diagnostics Division of Thermo Electron Corporation, to provide DRI ECSTASY PLUS 500 ML MDMA/MDA Reagent Kits for Tripler Army Medical Center in Hawaii. The contract has no set-aside designation and requires delivery by March 8, 2022. Microgenics Corporation, operating from its Fremont, California facility, will supply the requested reagent kits to support drug...
- The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $12,518.40 to Microgenics Corporation on August 1, 2025, for MDMA/MDA reagent kits (Part Number 10024631PSC). This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, will be performed in Fremont, California, and does not utilize a set-aside designation. Microgenics Corporation, a clinical diagnostics division subsidiary of Thermo Electron Corporation, specializes in manufacturing...
- <p>The Department of the Army Medical Command issued a $22,416 delivery order to Microgenics Corporation on May 26, 2026, for benzoylecgonine (BZE) immunoassay reagent kits supporting forensic toxicology drug testing at Tripler Army Medical Center, Fort Shafter, Hawaii, with an ultimate completion date of September 29, 2026.</p> <p>Place of performance is Fremont, California. The order is firm fixed price with no set-aside designation.</p>
- This is a delivery order award to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of MDMA/MDA reagent kits. The award, valued at $12,518.40, was made by the Navy Bureau of Medicine and Surgery, a component of the Department of Defense. This delivery order is issued against an existing $1.15 million single-award indefinite delivery contract held by Microgenics for the provision of these specialized diagnostic reagents. The MDMA/MDA reagent kits are used to...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $12,039 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA REAGENT. Microgenics Corporation, a division of Thermo Electron Corporation, will deliver the requested MDMA/MDA reagents under the contract to their place of performance in Fremont, California by July 23, 2021. No set-aside designation was applied to this solicitation for MDMA/MDA test reagents, which will support the Department...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $12,039 firm fixed price delivery order to Microgenics Corporation for DRI-ECSTASY PLUS MDMA/MDA REAGENT. Microgenics, a division of Thermo Electron Corporation, will deliver the requested drug identification and screening reagents to the place of performance in Fremont, California by the November 18, 2021 completion date. No set-aside designation was applied to this solicitation for MDMA/MDA reagents under the base IDIQ...
- This is a firm fixed-price delivery order contract awarded by the Navy Bureau of Medicine and Surgery, a defense agency, to Microgenics Corporation for the supply of MDMA/MDA reagent kits. The $12,518.40 contract has an ultimate completion date of December 18, 2024. Microgenics, a clinical diagnostics division of Thermo Electron Corporation, is an established supplier of immunoassay reagent test kits and other laboratory supplies to support the Department of Defense Drug Demand Reduction...
- This is a Firm Fixed Price delivery order awarded by the Defense Health Agency to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of Benzodiazepine Reagent Kits to support the Forensic Toxicology Drug Testing Laboratory (FTDTL) at Tripler Army Medical Center in Hawaii. The award has a total potential value of $101,518.56 and a completion date of March 19, 2024. Microgenics is a manufacturer of clinical diagnostic products and toxicology testing solutions, and...
Teaming
Find teaming partners for this award
- N0018924DZ018Indefinite Delivery Contract
- N0018924DZ018-W81K0026FA125Delivery Order
The Department of the Army issued a $37,555.20 delivery order to Microgenics Corporation on May 26, 2026, for MDA/MDMA reagent kits for forensic toxicology drug testing at Tripler Army Medical Center, Fort Shafter, Hawaii. Place of performance is Fremont, CA 94538. The order carries a firm fixed-price structure with an ultimate completion date of August 25, 2026. No set-aside applies to this order. The award references a parent single-award indefinite delivery contract for MDMA/MDA reagent kits with a ceiling of $1,154,822.40 (awarded by the Navy Bureau of Medicine and Surgery on March 15, 2024, with completion through March 14, 2029).
Generated 8/6/26, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.6k | 5/7/26 |